Empagliflozin rescues lifespan and liver senescence in naturally aged mice
GeroScience · 26.06.2024 · 46 (5) · 4969-4986
DOI: 10.1007/s11357-024-01250-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift GeroScience, online erschienen am 26.06.2024. Verfasst von Jiangchuan Long und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chong…. Hauptthemen laut MEDLINE: Glucosides, Benzhydryl Compounds, Liver, Longevity. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Empagliflozin is currently known to decrease blood glucose levels, delay renal failure, and reduce the risk of cardiovascular death and all-cause mortality in patients with type 2 diabetes with cardiovascular disease. However, the effects of empagliflozin on the lifespan and health of naturally aged organisms are unclear. This study was designed to investigate the impacts and potential mechanisms of empagliflozin on lifespan and liver senescence in naturally aged mice. Our study revealed that empagliflozin improved survival and health in naturally aged mice. Empagliflozin extended the median survival of male mice by 5.9%. Meanwhile, empagliflozin improved learning memory and motor balance, decreased body weight, and downregulated the hepatic protein expression of P21, P16, α-SMA, and COL1A1. Empagliflozin modulates the structure of the intestinal flora, increasing the relative abundance of Lachnospiraceae, Ruminococcaceae, Lactobacillus, Blautia, and Muribaculaceae and decreasing the relative abundance of Erysipelotrichaceae, Turicibacter, and Dubosiella in naturally aged mice. Further exploration discovered that empagliflozin increased the concentration of SCFAs, decreased the levels of the inflammatory factors TNF-α, IL-6, and CXCL9, and regulated the PI3K/AKT/P21 and AMPK/SIRT1/NF-κB pathways, which may represent the underlying mechanisms involved in these beneficial hepatic effects. Taken together, the above results indicated that empagliflozin intervention could be considered a potential strategy for extending lifespan and slowing liver senescence in naturally aged mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chongqing, 400010, China.
- College of Traditional Chinese Medicine, Chongqing Medical University, Chongqing, 400010, China.
- Institute of Life Sciences, School of Basic Medicine, Chongqing Medical University, Chongqing, 400010, China.
- Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chongqing, 400010, China. 300306@hospital.cqmu.edu.cn.
- Chongqing Clinical Research Center for Geriatrics and Gerontology, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chongqing, 400010, China. 300306@hospital.cqmu.edu.c…
Zitieren
APA
Long, J., Ren, Z., Duan, Y., Tao, W., Li, X., Li, S., Li, K., Huang, Q., Chen, J., Yang, M., Li, Y., Luo, X., & Liu, D. (2024). Empagliflozin rescues lifespan and liver senescence in naturally aged mice. GeroScience, 46(5), 4969-4986. https://doi.org/10.1007/s11357-024-01250-9
Vancouver
Long J, Ren Z, Duan Y, Tao W, Li X, Li S, et al. Empagliflozin rescues lifespan and liver senescence in naturally aged mice. GeroScience. 2024;46(5):4969-4986. doi:10.1007/s11357-024-01250-9
BibTeX
@article{Long2024,
author = {Long, Jiangchuan and Ren, Ziyu and Duan, Yaqian and Tao, Wei and Li, Xi and Li, Shengbing and Li, Ke and Huang, Qixuan and Chen, Jie and Yang, Mengliu and Li, Yang and Luo, Xie and Liu, Dongfang},
title = {Empagliflozin rescues lifespan and liver senescence in naturally aged mice},
journal = {GeroScience},
year = {2024},
volume = {46},
number = {5},
pages = {4969--4986},
doi = {10.1007/s11357-024-01250-9}
}
EUVIMED